Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 257–257 | Cite as

Infliximab

Skin atopic reaction: case report
Case report
  • 15 Downloads

Reference

  1. Tursi A, et al. Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: A real-life multicenter, observational study in italian primary inflammatory bowel disease centers. Annals of Gastroenterology 32: 392-399, No. 4, Jul-Aug 2019. Available from: URL: http://doi.org/10.20524/aog.2019.0377 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations